192 related articles for article (PubMed ID: 9641169)
21. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G
Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
[TBL] [Abstract][Full Text] [Related]
22. Production of less chronic nephrotoxicity by cyclosporine G than cyclosporine A in a low-salt rat model.
Burdmann EA; Rosen S; Lindsley J; Elzinga L; Andoh T; Bennett WM
Transplantation; 1993 May; 55(5):963-6. PubMed ID: 8497907
[TBL] [Abstract][Full Text] [Related]
23. Image analyser as a tool for the study of in vitro glomerular vasoreactivity.
Lakhdar B; Potier M; L'Azou B; Cambar J
Cell Biol Toxicol; 1994 Dec; 10(5-6):291-5. PubMed ID: 7697487
[TBL] [Abstract][Full Text] [Related]
24. Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture.
Ellouk-Achard S; Martin C; Pham-Huy C; Duc HT; Thevenin M; Dutertre-Catella H; Warnet JM; Claude JR
Arch Toxicol; 1997; 71(7):437-42. PubMed ID: 9209689
[TBL] [Abstract][Full Text] [Related]
25. Effects of leukotrienes on isolated rat glomeruli and cultured mesangial cells.
Barnett R; Goldwasser P; Scharschmidt LA; Schlondorff D
Am J Physiol; 1986 May; 250(5 Pt 2):F838-44. PubMed ID: 3706536
[TBL] [Abstract][Full Text] [Related]
26. [Demonstration of direct vasoconstrictive effect of cyclosporin on glomeruli isolated from human kidney].
Gonzalez R; Lakhdar B; Redon P; Potaux L; Cambar J; Aparicio M
C R Acad Sci III; 1990; 311(3):109-14. PubMed ID: 2119861
[TBL] [Abstract][Full Text] [Related]
27. Dopamine attenuates the contractile response to angiotensin II in isolated rat glomeruli and cultured mesangial cells.
Barnett R; Singhal PC; Scharschmidt LA; Schlondorff D
Circ Res; 1986 Nov; 59(5):529-33. PubMed ID: 3467880
[TBL] [Abstract][Full Text] [Related]
28. [Protective effect of verapamil and dopamine against cyclosporine-induced vasoconstriction in isolated glomeruli in rats].
L'Azou B; Lagroye I; Plande J; Lakhdar B; Cambar J
Presse Med; 1992 Dec; 21(41):2021-3. PubMed ID: 1294973
[TBL] [Abstract][Full Text] [Related]
29. A comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley rats.
Duncan JI; Thomson AW; Simpson JG; Davidson RJ; Whiting PH
Transplantation; 1986 Oct; 42(4):395-9. PubMed ID: 3765053
[TBL] [Abstract][Full Text] [Related]
30. Increased glomerular cell heparan sulfates in vitro by ciclosporin A: a Possible explanation of Its beneficial effect in idiopathic nephrotic syndrome.
Birmelé B; De Agostini A; Girardin EP
Nephron; 2001 Jun; 88(2):156-62. PubMed ID: 11399919
[TBL] [Abstract][Full Text] [Related]
31. Effects of cyclosporin and FK-506 on glomerular mesangial cells. Evidence for direct inhibition of thromboxane synthase by low cyclosporin concentrations.
Radeke HH; Kuster S; Kaever V; Resch K
Eur J Clin Pharmacol; 1993; 44 Suppl 1():S11-6. PubMed ID: 7683610
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporin A inhibits prostaglandin E2 formation by rat mesangial cells in culture.
Stahl RA; Adler S; Baker PJ; Johnson RJ; Chen YP; Pritzl P; Couser WG
Kidney Int; 1989 May; 35(5):1161-7. PubMed ID: 2504985
[TBL] [Abstract][Full Text] [Related]
33. Sites of biotransformation for the cyclosporin derivative SDZ IMM 125 using human liver and kidney slices and intestine. Comparison with rat liver slices and cyclosporin A metabolism.
Vickers AE; Fisher RL; Brendel K; Guertler J; Dannecker R; Keller B; Fischer V
Drug Metab Dispos; 1995 Mar; 23(3):327-33. PubMed ID: 7628297
[TBL] [Abstract][Full Text] [Related]
34. Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
Chansel D; Badre L; Czekalski S; Vandermeersch S; Cambar J; Ardaillou R
J Pharmacol Exp Ther; 1993 Jun; 265(3):1534-43. PubMed ID: 8510026
[TBL] [Abstract][Full Text] [Related]
35. Role of endothelin in cyclosporine-induced glomerular dysfunction.
Kon V; Sugiura M; Inagami T; Harvie BR; Ichikawa I; Hoover RL
Kidney Int; 1990 Jun; 37(6):1487-91. PubMed ID: 2194067
[TBL] [Abstract][Full Text] [Related]
36. Direct effects of platelet-activating factor on glomerular capillary permeability.
Sharma R; Sharma M; Li JZ; McCarthy ET; Savin VJ
Kidney Blood Press Res; 1997; 20(1):25-30. PubMed ID: 9192907
[TBL] [Abstract][Full Text] [Related]
37. Effect of cyclosporin and the prostacyclin analogue iloprost on human glomerular vasoreactivity.
Le Guen E; Morel D; L'Azou B; Cambar J; Potaux L
Nephrol Dial Transplant; 1994; 9(4):413-5. PubMed ID: 7521943
[TBL] [Abstract][Full Text] [Related]
38. Effects of cyclosporin A on proliferation of cultured rat mesangial cells.
Sun J; Wang Y
J Tongji Med Univ; 1997; 17(2):115-7. PubMed ID: 9639803
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines.
Langman LJ; Yatscoff RW
Ther Drug Monit; 1994 Oct; 16(5):450-7. PubMed ID: 7846742
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelinB receptor.
Tack I; Marin-Castano E; Bascands JL; Pecher C; Ader JL; Girolami JP
Br J Pharmacol; 1997 Jun; 121(3):433-40. PubMed ID: 9179384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
